ATE454906T1 - Feste zusammensetzung mit einem protonenpumpenhemmer - Google Patents

Feste zusammensetzung mit einem protonenpumpenhemmer

Info

Publication number
ATE454906T1
ATE454906T1 AT04749149T AT04749149T ATE454906T1 AT E454906 T1 ATE454906 T1 AT E454906T1 AT 04749149 T AT04749149 T AT 04749149T AT 04749149 T AT04749149 T AT 04749149T AT E454906 T1 ATE454906 T1 AT E454906T1
Authority
AT
Austria
Prior art keywords
proton pump
pump inhibitor
solid composition
pellets
composition containing
Prior art date
Application number
AT04749149T
Other languages
English (en)
Inventor
Eva Blychert
Marjo Janssen
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Application granted granted Critical
Publication of ATE454906T1 publication Critical patent/ATE454906T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT04749149T 2003-07-11 2004-07-08 Feste zusammensetzung mit einem protonenpumpenhemmer ATE454906T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US48679503P 2003-07-11 2003-07-11
PCT/SE2004/001113 WO2005004921A1 (en) 2003-07-11 2004-07-08 Solid composition comprising a proton pump inhibitor

Publications (1)

Publication Number Publication Date
ATE454906T1 true ATE454906T1 (de) 2010-01-15

Family

ID=34062141

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04749149T ATE454906T1 (de) 2003-07-11 2004-07-08 Feste zusammensetzung mit einem protonenpumpenhemmer

Country Status (7)

Country Link
US (1) US20070053981A1 (de)
EP (1) EP1646404B1 (de)
JP (1) JP2007522086A (de)
AT (1) ATE454906T1 (de)
DE (1) DE602004025113D1 (de)
ES (1) ES2338009T3 (de)
WO (1) WO2005004921A1 (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI372066B (en) 2003-10-01 2012-09-11 Wyeth Corp Pantoprazole multiparticulate formulations
JP2008502740A (ja) * 2004-06-15 2008-01-31 テバ ファーマシューティカル インダストリーズ リミティド ベンズイミダゾール化合物の安定医薬製剤
US20090068263A1 (en) * 2006-04-20 2009-03-12 Themis Laboratories Private Limited Multiple unit compositions
CH698658B1 (de) * 2006-04-24 2009-09-30 Mepha Ag Orale pharmazeutische Formulierung mit schneller Freisetzung für Pyridylmethylsulfinyl-Benzimidazole.
ITMI20062290A1 (it) * 2006-11-28 2008-05-29 Monteres S R L Compresse stabili allo stoccaggio a base di derivati del benzimidazolo rivestite con film gastro-resistente
JP2012072061A (ja) * 2009-01-29 2012-04-12 Eisai R & D Management Co Ltd 新規組成物
US20110066141A1 (en) * 2009-09-11 2011-03-17 Cook Incorporated Implantable medical device having an anti-gastric distress agent
US20140179637A1 (en) 2012-12-21 2014-06-26 The Research Foundation For The State University Of New York Methods and compounds to inhibit enveloped virus release
GB2535130B (en) * 2014-09-29 2020-09-02 Veriton Pharma Ltd A Suspension
MX378262B (es) * 2015-03-31 2025-03-10 Laboratorios Bago S A Procedimiento de elaboración de pellets entéricos que contienen un inhibidor de la bomba protónica y composiciones farmacéuticas multiparticuladas que los contienen.
US20170042806A1 (en) 2015-04-29 2017-02-16 Dexcel Pharma Technologies Ltd. Orally disintegrating compositions
CN105125507B (zh) * 2015-08-19 2018-03-06 德州德药制药有限公司 一种埃索美拉唑钠注射用冻干粉组合物及其制备方法
WO2017145146A1 (en) 2016-02-25 2017-08-31 Dexcel Pharma Technologies Ltd. Compositions comprising proton pump inhibitors
US10076494B2 (en) 2016-06-16 2018-09-18 Dexcel Pharma Technologies Ltd. Stable orally disintegrating pharmaceutical compositions
US10137111B2 (en) 2016-08-11 2018-11-27 Adamis Pharmaceuticals Corporation Drug compositions comprising an anti-parasitic and proton pump inhibitor
US10946002B2 (en) * 2016-10-06 2021-03-16 Jubilant Generics Limited Pharmaceutical suspension dosage form of benzimidazole compounds and process of preparation thereof
WO2019113493A1 (en) 2017-12-08 2019-06-13 Adamis Pharmaceuticals Corporation Drug compositions
KR102006777B1 (ko) * 2018-01-29 2019-10-08 주식회사 종근당 에스오메프라졸 및 탄산수소나트륨을 포함하는 약제학적 제제
KR102080023B1 (ko) 2018-01-29 2020-02-21 주식회사 종근당 에스오메프라졸 및 탄산수소나트륨을 포함하는 안정한 약제학적 조성물
US12251375B2 (en) 2018-08-23 2025-03-18 Chong Kun Dang Pharmaceutical Corp. Pharmaceutical preparation having excellent dissolution properties, containing esomeprazole and sodium bicarbonate
US11666562B2 (en) 2020-04-02 2023-06-06 Northwestern University Ilaprazole for inhibiting the release of enveloped viruses from cells
WO2023137556A1 (en) * 2022-01-20 2023-07-27 Bionxt Solutions Inc. Chemical composition for enteric drug delivery
KR102553713B1 (ko) * 2022-11-18 2023-07-10 고덕상 미네랄 촉매제를 이용한 양식어류사료 제조방법

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK130287D0 (da) * 1987-03-13 1987-03-13 Benzon As Alfred Oralt praeparat
US5108767A (en) * 1991-06-10 1992-04-28 Abbott Laboratories Liquid nutritional product for persons receiving renal dialysis
DK0662320T3 (da) * 1991-08-30 2001-09-24 Showa Pharm Chem Ind Tør gelsammensætning
SE9301489D0 (sv) * 1993-04-30 1993-04-30 Ab Astra Veterinary composition
IT1270216B (it) * 1994-06-14 1997-04-29 Recordati Chem Pharm Metodo di stabilizzazione di composti biologicamente attivi mediante microgranuli ricoperti sospendibili in fluidi alimentari
DK0723436T3 (da) * 1994-07-08 2001-11-26 Astrazeneca Ab Tabletteret flerenhedsdoseringsform
SE9402431D0 (sv) * 1994-07-08 1994-07-08 Astra Ab New tablet formulation
US6645988B2 (en) * 1996-01-04 2003-11-11 Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
GB2318511A (en) * 1996-10-23 1998-04-29 Eurand Int Process for the preparation of a pharmaceutical composition for rapid suspension in water
US5869118A (en) * 1996-11-13 1999-02-09 Abbott Laboratories Gellan gum to improve physical stability of liquid nutritional products
US5759579A (en) * 1996-12-05 1998-06-02 American Home Products Corporation Pharmaceutical suspension systems
AU4802699A (en) * 1998-07-31 2000-02-21 Otsuka Pharmaceutical Co., Ltd. Pharmaceutical composition having improved taste
WO2002026210A2 (en) * 2000-09-29 2002-04-04 Geneva Pharmaceuticals Inc. Proton pump inhibitor formulation

Also Published As

Publication number Publication date
US20070053981A1 (en) 2007-03-08
JP2007522086A (ja) 2007-08-09
EP1646404B1 (de) 2010-01-13
ES2338009T3 (es) 2010-05-03
EP1646404A1 (de) 2006-04-19
DE602004025113D1 (de) 2010-03-04
WO2005004921A1 (en) 2005-01-20

Similar Documents

Publication Publication Date Title
ATE454906T1 (de) Feste zusammensetzung mit einem protonenpumpenhemmer
RU2356547C2 (ru) Способы лечения рака с использованием ингибиторов hdac
EA200400777A1 (ru) Фармацевтические композиции соединения платины
RU2002115283A (ru) Фармацевтические композиции противотуберкулезных лекарственных средств и способ их изготовления
TR200002786T2 (tr) Meloksikam için yeni galenik bir formülasyon.
KR870009718A (ko) 경구용 산에 불안정한물질의 약제
EP1529527A3 (de) Valproinsäure zur Kombinationsbehandlung von Krebs bei Menschen und zur Behandlung von Tumormetastasen und minimaler Resterkrankung
TW200635618A (en) Solid dosage form comprising proton pump inhibitor and suspension made thereof
WO2007078874A3 (en) Oral pharmaceutical formulations containing non-steroidal anti-inflammatory drugs and acid inhibitors
PL358103A1 (pl) Hydrofilowe molekularne roztwory dyspersyjne karwedilolu
KR880008803A (ko) 핵을 갖는 구형 과립 및 그의 제조방법
DK1414459T3 (da) Oral doseringsform omfattende et terapeutisk middel og et middel med skadevirkning
JP2005537234A5 (de)
JP2006516272A5 (de)
JP2005503399A5 (de)
GEP20043285B (en) Sustained Release Beadlets Containing Stavudine, Method for Their Production, Pharmaceutical Composition Containing the Same and Use Thereof for Treatment Retroviral Infections
ATE549015T1 (de) Pharmazeutische wirkstoffhaltige formulierung mit überzug
ATE466008T1 (de) P-glycoprotein-inhibitor, verfahren zu dessen herstellung und pharmazeutische zusammensetzung, die diesen enthält
CA2502731A1 (en) Sustained release composition for oral administration of drugs
DE60229295D1 (de) Komprimierte, orale pharmazeutische dosierungsform mit enterischer beschichtung, die eine säurelabile benzimidazolverbindung enthält
RU2005105302A (ru) Композиция бицифадина
ATE462419T1 (de) Orale pharmazeutische zusammensetzung für weichkapseln mit vinorelbin und behandlungsverfahren
TWI482632B (zh) 醫藥用載體及使用該載體的藥物結構
WO2002062299A3 (en) Improved controlled release oral dosage form
US5998478A (en) Timed release tablet comprising naproxen and pseudoephedrine

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties